GlassScriptPhysician profile
Martin A Lesser
NPI 1972553535
$880.78
in general payments reported to CMS, 2019-2025
9 companies · $65.65 in 2025
The $65.65 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $242 · 2023: $158 · 2024: $23.64 · 2025: $65.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $351.56 | 2019-2020 | |
| Abbott Laboratories | $161.20 | 2019 | |
| Eisai INC. | $142.34 | 2023-2025 | |
| Amarin Pharma, INC. | $120.83 | 2020 | |
| Lilly USA, LLC | $25.42 | 2025 | Kisunla |
| Avid Radiopharmaceuticals, INC. | $23.64 | 2024 | |
| Life Molecular Imaging LTD | $22.69 | 2023 | Neuraceq |
| Ceribell, INC. | $20.00 | 2025 | Pocket Eeg Device |
| Janssen Pharmaceuticals, INC | $13.10 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Lesser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.